Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Victoria, British Columbia, company, gained to close at $23.51 Thursday after gaining $0.08 (0.34%) on volume of 3,102,729 shares. The stock ranged from a high of $23.95 to a low of $22.88 while Aurinia’s market cap now stands at $3,018,588,244.
About Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.